Skip to main content
Clinical Trials/JPRN-UMIN000010258
JPRN-UMIN000010258
Completed
未知

Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myeloma - SMUIM4-MM02

Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine0 sites30 target enrollmentMarch 18, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 18, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients HIV\-HBs\-and HCV\-positive. 2\) Severe hepatic dysfunction, severe renal failure, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled diabetes, uncontrolled hypertension, and uncontrolled infection. 3\) Patients with a history of active malignancy. 4\) Patients with severe psychiatric disorders. 5\) Patients with pregnancy or lactation. 6\) Those who are considered as inappropriate to register by attending physicians.

Outcomes

Primary Outcomes

Not specified

Similar Trials